Joan Bladé Selected Research

Paraproteins

1/2022	Prognostic Value of Serum Paraprotein Response Kinetics in Patients With Newly Diagnosed Multiple Myeloma.
5/2019	Pomalidomide-dexamethasone for treatment of soft-tissue plasmacytomas in patients with relapsed / refractory multiple myeloma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joan Bladé Research Topics

Disease

140	Multiple Myeloma 02/2024 - 05/2002
15	Disease Progression 01/2021 - 01/2005
12	Immunoglobulin Light-chain Amyloidosis 04/2024 - 01/2006
12	Monoclonal Gammopathy of Undetermined Significance 02/2024 - 05/2002
11	Neoplasms (Cancer) 01/2022 - 07/2004
9	Smoldering Multiple Myeloma 05/2024 - 09/2005
9	Peripheral Nervous System Diseases (PNS Diseases) 10/2014 - 08/2004
8	Paraproteinemias (Monoclonal Gammopathy) 02/2024 - 03/2003
7	Plasmacytoma 01/2022 - 05/2004
6	Amyloidosis 01/2023 - 10/2012
6	Fatigue 04/2016 - 08/2004
6	Thrombocytopenia (Thrombopenia) 01/2015 - 04/2005
6	Renal Insufficiency (Renal Failure) 06/2011 - 08/2004
5	Infections 10/2023 - 01/2005
5	Neutropenia 01/2019 - 10/2008
5	Pathologic Complete Response 01/2014 - 12/2009
4	Residual Neoplasm 09/2021 - 01/2012
3	Waldenstrom Macroglobulinemia (Macroglobulinemia) 04/2021 - 04/2003
3	Hemorrhage 02/2009 - 02/2008
2	Frailty 04/2024 - 11/2021
2	Hematologic Neoplasms (Hematological Malignancy) 11/2023 - 12/2021
2	Lymphoma (Lymphomas) 01/2021 - 04/2003
2	Asthenia 08/2016 - 10/2014
2	Constipation 05/2012 - 08/2004
2	Chromosome Aberrations (Chromosome Abnormalities) 10/2011 - 04/2008
2	Anemia 02/2010 - 04/2005
2	Plasma Cell Leukemia 10/2008 - 04/2005
2	Necrosis 07/2002 - 05/2002
1	Drug-Related Side Effects and Adverse Reactions 11/2023
1	Genetic Translocation (Chromosomal Translocation) 10/2022
1	Thrombotic Microangiopathies 01/2021

Drug/Important Bio-Agent (IBA)

54	Bortezomib (Velcade)FDA Link 02/2024 - 01/2005
38	Dexamethasone (Maxidex)FDA LinkGeneric 02/2024 - 01/2005
23	Proteins (Proteins, Gene)FDA Link 05/2024 - 04/2003
21	Lenalidomide (CC 5013)FDA Link 12/2023 - 04/2008
20	Thalidomide (Thalomid)FDA Link 01/2023 - 03/2003
17	Melphalan (Alkeran)FDA LinkGeneric 11/2021 - 01/2005
12	Prednisone (Sone)FDA LinkGeneric 11/2021 - 10/2006
10	Biomarkers (Surrogate Marker)IBA 12/2023 - 07/2012
9	daratumumabIBA 02/2024 - 04/2016
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2023 - 10/2008
6	Proteasome InhibitorsIBA 01/2021 - 01/2005
6	liposomal doxorubicin (Doxil)FDA Link 07/2016 - 09/2007
5	Monoclonal AntibodiesIBA 01/2020 - 06/2012
5	1-dodecylpyridoxal (PLD)IBA 07/2016 - 09/2007
4	Immunoglobulins (Immunoglobulin)IBA 11/2023 - 01/2011
4	Immunoglobulin M (IgM)IBA 01/2023 - 04/2003
4	Amyloid (Amyloid Fibrils)IBA 12/2021 - 10/2014
4	Alkylating AgentsIBA 01/2021 - 05/2006
4	Immunoglobulin G (IgG)IBA 10/2018 - 02/2009
4	Immunomodulating AgentsIBA 10/2017 - 11/2010
4	Proteasome Endopeptidase Complex (Proteasome)IBA 11/2012 - 11/2007
3	carfilzomibIBA 10/2023 - 01/2019
3	melflufenIBA 01/2022 - 09/2020
3	PanobinostatIBA 01/2021 - 10/2013
3	pomalidomideIBA 01/2021 - 05/2019
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 01/2005
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2020 - 02/2008
3	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 01/2020 - 09/2015
3	Oligoclonal BandsIBA 08/2017 - 12/2009
3	Interleukin-6 (Interleukin 6)IBA 06/2014 - 05/2002
3	Busulfan (Busulfex)FDA Link 01/2013 - 12/2007
3	DNA (Deoxyribonucleic Acid)IBA 11/2012 - 05/2005
2	Complement System Proteins (Complement)IBA 04/2024 - 01/2021
2	ParaproteinsIBA 01/2022 - 05/2019
2	Chimeric Antigen ReceptorsIBA 12/2021 - 12/2019
2	AminopeptidasesIBA 01/2021 - 09/2020
2	Peptides (Polypeptides)IBA 01/2021 - 09/2020
2	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 01/2020 - 05/2005
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 08/2004
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 07/2015 - 01/2014
2	MicroRNAs (MicroRNA)IBA 01/2015 - 07/2012
2	siltuximabIBA 01/2015 - 06/2014
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 07/2014 - 04/2008
2	thiamine triphosphorate (TTP)IBA 05/2014 - 04/2008
2	CytokinesIBA 09/2011 - 05/2002
2	Cytotoxins (Cytolysins)IBA 01/2011 - 01/2005
1	pro-brain natriuretic peptide (1-76)IBA 04/2024
1	selinexorIBA 02/2024
1	Immunoglobulin D (IgD)IBA 02/2024
1	NucleotidesIBA 10/2022
1	Immunoglobulin A (IgA)IBA 01/2022
1	Protein Isoforms (Isoforms)IBA 01/2022
1	Serum AlbuminIBA 01/2022
1	B-Cell Maturation AntigenIBA 12/2021
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 12/2021
1	filanesibIBA 01/2021

Therapy/Procedure

64	Therapeutics 12/2023 - 11/2003
30	Stem Cell Transplantation 01/2022 - 05/2006
11	Transplantation 12/2023 - 06/2002
5	Autologous Transplantation 07/2013 - 09/2006
5	Drug Therapy (Chemotherapy) 05/2010 - 12/2005
4	Aftercare (After-Treatment) 01/2022 - 10/2008
4	Hematopoietic Stem Cell Transplantation 12/2018 - 12/2009
2	Kidney Transplantation 11/2021 - 08/2011
2	Salvage Therapy 05/2012 - 08/2004
2	Induction Chemotherapy 01/2011 - 11/2010
2	Hematopoietic Stem Cell Mobilization 02/2009 - 02/2008
1	Intravenous Administration 10/2022
1	Hemodilution 09/2021